Schwannoma
Symptoms, Doctors, Treatments, Advances & More

Schwannoma Overview

Save information for later
Sign Up

Learn About Schwannoma

View Main Condition: Brain Tumor

What is the definition of Schwannoma?
A Schwannoma is a tumor of the peripheral nervous system or nerve root. A Schwannoma develops from cells called Schwann cells, a type of cell that wraps itself around peripheral nerves and provides protection and support. Schwannomas are almost always benign (not cancerous), but rarely, may become cancerous (a malignant Schwannoma). Symptoms of a Schwannoma may be vague and will vary depending on its location and size, but may include a lump or bump that can be seen or felt, pain, muscle weakness, tingling, numbness, hearing problems, and/or facial paralysis. Sometimes Schwannomas do not cause any symptoms. Schwannomas usually develop in otherwise healthy people for unknown reasons. In some cases, a Schwannoma is caused by a genetic disorder such as neurofibromatosis 2 (NF2), Schwannomatosis, or Carney complex. People with these genetic disorders usually have more than one Schwannoma. Schwannomas may be diagnosed using imaging studies. A biopsy may confirm the diagnosis.
What are the alternative names for Schwannoma?
  • Schwannoma
  • Benign schwannoma
  • Neurilemmoma
  • Neurilemoma
  • Neurolemmoma
  • Peripheral fibroblastoma
Who are the top Schwannoma Local Doctors?
Elite in Schwannoma
Dr. Fred F. Telischi
Otolaryngology
Elite in Schwannoma
Dr. Fred F. Telischi
Otolaryngology
Referral may be required
1120 Northwest 14th Street, 
Miami, FL 
305-243-3564
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Fred Telischi is an Otolaryngologist practicing medicine in Miami, Florida. Dr. Telischi is rated as an Elite provider by MediFind in the treatment of Schwannoma. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Schwannoma, Acoustic Neuroma, Neurofibromatosis Type 2 (NF2), Neuroendocrine Tumor, and Mastoidectomy. Dr. Telischi is currently accepting new patients.

Elite in Schwannoma
Elite in Schwannoma
Referral may be required

Corewell Health William Beaumont University Hospital Neurology - 3555 W 13 Mile

3555 West 13 Mile Road, Suite N120, 
Royal Oak, MI 
855-863-8761
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jeffrey Jacob is a Neurosurgery provider practicing medicine in Royal Oak, Michigan. Dr. Jacob is rated as an Elite provider by MediFind in the treatment of Schwannoma. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Acoustic Neuroma, Schwannoma, Subependymoma, Gamma Knife Radiosurgery, and Awake Craniotomy. Dr. Jacob is board certified in American Board Of Neurological Surgery. Dr. Jacob is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Schwannoma
Dr. Seilesh C. Babu
Otolaryngology
Elite in Schwannoma
Dr. Seilesh C. Babu
Otolaryngology
Referral may be required

Michigan Ear Institute

30055 Northwestern Highway, Suite 101, 
Farmington Hills, MI 
248-865-4444
Experience:
29+ years
Languages Spoken:
English, Spanish, Telugu
See accepted insurances
Accepting New Patients
Offers Telehealth

Seilesh Babu is an Otolaryngologist practicing medicine in Farmington Hills, Michigan. He has been practicing medicine for over 29 years. Dr. Babu is rated as an Elite provider by MediFind in the treatment of Schwannoma. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Acoustic Neuroma, Schwannoma, Otosclerosis, Stapedectomy, and Mastoidectomy. Dr. Babu is board certified in American Board Of Otolaryngology - Head And Neck Surgery and American Board Of Otolaryngology - Head And Neck Surgery. Dr. Babu is currently accepting new patients.

View All Doctors
What are the latest Schwannoma Clinical Trials?
Immunotherapy Targeting Neurofibromatosis or Schwannomatosis
Immunotherapy Targeting Neurofibromatosis or Schwannomatosis
Who is this study for: Patients with neurofibromatosis or schwannomatosis
Enrollment Status: Recruiting
Publish Date: June 18, 2026
Intervention Type: Biological
Study Drug: Antigen-specific T cells CART+CTL+DCvac
Study Phase: Phase 1/Phase 2

Summary: The primary objective of this study is to verify the safety of antigen-specific T cells (CAR-T) and engineered immune effector cytotoxic T cells (EIE) modified by immunoregulatory genes and immune modified dendritic cell vaccine (DCvac) in the treatment of neurofibromatosis or schwannoma.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Familial Investigations of Childhood Cancer Predisposition
Familial Investigations of Childhood Cancer Predisposition
Enrollment Status: Recruiting
Publish Date: June 17, 2026

Summary: NOTE: This is a research study and is not meant to be a substitute for clinical genetic testing. Families may never receive results from the study or may receive results many years from the time they enroll. If you are interested in clinical testing please consider seeing a local genetic counselor or other genetics professional. If you have already had clinical genetic testing and meet eligibility...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center